-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Upgrades Ingevity to Outperform, Raises Price Target to $65

Benzinga·02/26/2025 14:54:17
Listen to the news
BMO Capital analyst John McNulty upgrades Ingevity (NYSE:NGVT) from Market Perform to Outperform and raises the price target from $62 to $65.